Total Payments
$4,133
2024 Payments
$890.48
Companies
30
Transactions
198
Medicare Patients
13,739
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$3,925 (95.0%)
Education$208.00 (5.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,925 | 195 | 95.0% |
| Education | $208.00 | 3 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $595.67 | 39 | $0 (2024) |
| Astellas Pharma US Inc | $373.58 | 13 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $317.53 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $273.56 | 11 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $251.04 | 11 | $0 (2022) |
| Merck Sharp & Dohme LLC | $242.26 | 15 | $0 (2024) |
| Medtronic, Inc. | $232.69 | 4 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $227.21 | 6 | $0 (2024) |
| Novo Nordisk Inc | $205.82 | 11 | $0 (2024) |
| Abbott Laboratories | $203.32 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $890.48 | 42 | Amgen Inc. ($147.08) |
| 2023 | $267.54 | 15 | Merck Sharp & Dohme LLC ($69.56) |
| 2022 | $469.37 | 18 | Edwards Lifesciences Corporation ($191.64) |
| 2021 | $447.55 | 19 | Boehringer Ingelheim Pharmaceuticals, Inc. ($164.69) |
| 2020 | $238.33 | 14 | Amgen Inc. ($70.40) |
| 2019 | $923.28 | 34 | Astellas Pharma US Inc ($281.10) |
| 2018 | $379.59 | 25 | Amgen Inc. ($81.64) |
| 2017 | $517.01 | 31 | Amgen Inc. ($121.95) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.51 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Obesity | ||||||
| 10/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Cardiology | ||||||
| 09/27/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.67 | General |
| Category: Cardiovascular | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Obesity | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $143.66 | General |
| Category: Pacemakers | ||||||
| 08/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Not Applicable | ||||||
| 08/05/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/01/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Cardiology | ||||||
| 07/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Cardiology | ||||||
| 06/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,860 | 5,698 | $1.6M | $356,001 |
| 2022 | 24 | 2,812 | 4,380 | $1.5M | $364,854 |
| 2021 | 29 | 3,644 | 7,207 | $1.7M | $420,064 |
| 2020 | 32 | 4,423 | 10,573 | $1.9M | $463,949 |
Total Patients
13,739
Total Services
27,858
Medicare Billing
$1.6M
Procedure Codes
119
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 272 | 272 | $422,144 | $85,956 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 431 | 718 | $132,830 | $62,170 | 46.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 272 | 546 | $95,550 | $47,386 | 49.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 324 | 338 | $339,690 | $39,088 | 11.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 234 | 235 | $110,450 | $29,113 | 26.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 135 | 541 | $74,388 | $23,556 | 31.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 270 | 270 | $91,800 | $12,564 | 13.7% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 205 | 214 | $100,152 | $9,293 | 9.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 37 | 155 | $35,650 | $8,038 | 22.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $15,180 | $7,119 | 46.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 35 | 35 | $19,705 | $5,206 | 26.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 107 | 211 | $15,825 | $4,127 | 26.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 53 | 66 | $11,088 | $3,740 | 33.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 128 | 245 | $15,925 | $3,508 | 22.0% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 17 | 17 | $23,647 | $3,417 | 14.5% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 29 | 29 | $6,525 | $2,490 | 38.2% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 31 | 127 | $8,255 | $2,148 | 26.0% |
| 93283 | Programming of dual lead implantable defibrillator system | Office | 2023 | 17 | 21 | $3,675 | $1,462 | 39.8% |
| 75572 | Ct scan of heart structure with contrast | Facility | 2023 | 15 | 15 | $12,870 | $959.25 | 7.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 19 | 19 | $7,629 | $950.58 | 12.5% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 20 | 20 | $2,920 | $942.07 | 32.3% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 24 | 36 | $7,045 | $897.92 | 12.7% |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | Office | 2023 | 20 | 1,360 | $5,440 | $784.29 | 14.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 47 | 77 | $1,155 | $646.80 | 56.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 40 | 53 | $1,723 | $327.50 | 19.0% |
About Dr. Lyle Zepick, M.D
Dr. Lyle Zepick, M.D is a Specialist healthcare provider based in Wichita, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346294808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lyle Zepick, M.D has received a total of $4,133 in payments from pharmaceutical and medical device companies, with $890.48 received in 2024. These payments were reported across 198 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,925).
As a Medicare-enrolled provider, Zepick has provided services to 13,739 Medicare beneficiaries, totaling 27,858 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Wichita, KS
- Active Since 05/20/2006
- Last Updated 06/24/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1346294808
Products in Payments
- Repatha (Biological) $441.34
- JARDIANCE (Drug) $317.53
- VERQUVO (Drug) $242.26
- UPTRAVI (Drug) $188.36
- EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) $166.39
- Corlanor (Drug) $144.33
- PRALUENT (Drug) $143.78
- MICRA (Device) $143.66
- LEXISCAN (Drug) $143.57
- BRILINTA (Drug) $139.18
- FARXIGA (Drug) $134.38
- MULTAQ (Drug) $107.26
- PRALUENT ALIROCUMAB INJECTION (Biological) $104.43
- ENTRESTO (Drug) $102.19
- Wegovy (Drug) $91.11
- XARELTO (Drug) $69.36
- Vascepa (Drug) $68.52
- Arcalyst (Drug) $60.13
- PRALUENT (Biological) $55.77
- LifeVest (Device) $51.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Wichita
Eva Henry, M.d, M.D
Specialist — Payments: $92,445
Specialist $92,445
Dr. Dennis Ross, M.d, M.D
Specialist — Payments: $28,748
Specialist $28,748
Dr. Matthew Conrad, M.d, M.D
Specialist — Payments: $25,839
Specialist $25,839
Olga Tatpati, M.d, M.D
Specialist — Payments: $5,719
Specialist $5,719
Anna Stork-Fury, D.o, D.O
Specialist — Payments: $3,901
Specialist $3,901
Mrs. Karen Bohaty, Pa-C, PA-C
Specialist — Payments: $3,755
Specialist $3,755